Is OXFCF or JNJ a better dividend investment in 2026?

OXFCF currently yields 66666.67% with a 5% 5-year dividend growth rate. JNJ yields 2.14% with 5.8% growth. The better choice depends on your goal: OXFCF offers higher current income.

What is the dividend yield difference between OXFCF and JNJ?

OXFCF has a forward dividend yield of 66666.67% ($2.00/share annually). JNJ yields 2.14% ($5.20/share annually). The yield gap is 66664.53 percentage points.

Home › Compare › OXFCF vs JNJ

OXFCF vs JNJ: Dividend Comparison 2026

OXFCF yields 66666.67% · JNJ yields 2.14%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 OXFCF wins by $8.441837856534449e+24M in total portfolio value

INVESTMENT

TIME HORIZON10 years

OXFCF

● Live price

66666.67%

Share price

$0.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$8.441837856534449e+24M

Annual income

$8,417,001,582,403,749,000,000,000,000,000.00

Full OXFCF calculator →

JNJ

Johnson & Johnson

● Live price

2.14%

Share price

$242.49

Annual div

$5.20

5Y div CAGR

28%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.5K

Annual income

$4,749.88

Full JNJ calculator →

Portfolio growth — OXFCF vs JNJ

📍 OXFCF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	OXFCF	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, OXFCF + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

OXFCF pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

OXFCF

Annual income on $10K today (after 15% tax)

$5,666,666.67/yr

After 10yr DRIP, annual income (after tax)

$7,154,451,345,043,187,000,000,000,000,000.00/yr

JNJ

Annual income on $10K today (after 15% tax)

$182.28/yr

After 10yr DRIP, annual income (after tax)

$4,037.40/yr

At 15% tax rate, OXFCF beats the other by $7,154,451,345,043,187,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of OXFCF + JNJ for your $10,000?

OXFCF: 50%JNJ: 50%

100% JNJ50/50100% OXFCF

Portfolio after 10yr

$4.2209189282672247e+24M

Annual income

$4,208,500,791,201,874,400,000,000,000,000.00/yr

Blended yield

99.71%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

OXFCF

No analyst data

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

-5.7% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

OXFCF buys

JNJ buys

No recent congressional trades found for OXFCF or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricOXFCFJNJ

Forward yield	66666.67% ✓	2.14%
Annual dividend / share	$2.00	$5.20 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	28% ✓
Portfolio after 10y	$8.441837856534449e+24M	$30.5K ✓
Annual income after 10y	$8,417,001,582,403,749,000,000,000,000,000.00 ✓	$4,749.88
Total dividends collected	$8.44020886744369e+24M	$15.6K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: OXFCF vs JNJ ($10,000, DRIP)

Year	OXFCF Portfolio	OXFCF Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$6,677,367	$6,666,666.67	$10,594	$274.49	+$6.67M → OXFCF
2	$4,167,497,846	$4,160,353,063.34	$11,294	$360.69	+$4167.49M → OXFCF
3	$2,431,161,901,635	$2,426,702,678,939.67	$12,133	$476.91	+$2431161.89M → OXFCF
4	$1,325,636,209,022,888	$1,323,034,865,788,139.00	$13,156	$635.42	+$1325636209.01M → OXFCF
5	$675,632,775,263,916,700	$674,214,344,520,262,300.00	$14,432	$854.61	+$675632775263.90M → OXFCF
6	$321,867,481,182,444,260,000	$321,144,554,112,911,900,000.00	$16,056	$1,162.76	+$321867481182444.25M → OXFCF
7	$143,326,993,661,751,470,000,000	$142,982,595,456,886,240,000,000.00	$18,175	$1,604.53	+$143326993661751472.00M → OXFCF
8	$59,657,925,421,851,500,000,000,000	$59,504,565,538,633,426,000,000,000.00	$21,009	$2,252.68	+$59657925421851500544.00M → OXFCF
9	$23,211,471,150,187,795,000,000,000,000	$23,147,637,169,986,416,000,000,000,000.00	$24,911	$3,229.73	+$2.3211471150187796e+22M → OXFCF
10	$8,441,837,856,534,450,000,000,000,000,000	$8,417,001,582,403,749,000,000,000,000,000.00	$30,458	$4,749.88	+$8.441837856534449e+24M → OXFCF

OXFCF vs JNJ: Complete Analysis 2026

OXFCF — Stock

Velocys plc operates as a renewable fuels company. It designs, develops, and licenses its Fischer-Tropsch technology for the generation of clean, low carbon, and synthetic drop-in aviation and road transport fuel from municipal solid waste and residual woody biomass plants. It has operations in the Americas and the Asia Pacific. The company was formerly known as Oxford Catalysts Group PLC and changed its name to Velocys plc in September 2013. Velocys plc was incorporated in 2006 and is headquartered in Oxford, the United Kingdom.

Full OXFCF Calculator →

JNJ — Healthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →

📬

Get this OXFCF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

OXFCF vs SCHD OXFCF vs JEPI OXFCF vs O OXFCF vs KO OXFCF vs MAIN OXFCF vs ABBV OXFCF vs MRK OXFCF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.